Atomoxetine for the treatment of pediatric nocturnal enuresis

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 3, 2004, Pages 443-447

  Shatkin, Jess P ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLONIDINE; DESMOPRESSIN ACETATE; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; PROPRANOLOL; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VASOPRESSIN DERIVATIVE;

ADD ON THERAPY; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CASE REPORT; CHILD; COMORBIDITY; DEVICE; DOSE CALCULATION; DRUG EFFICACY; ENURESIS ALARM; HUMAN; MALE; NOCTURNAL ENURESIS; PSYCHOPHARMACOTHERAPY; TACHYCARDIA; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; ENURESIS; HUMANS; MALE; PROPYLAMINES;

EID: 8144221769     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2004.14.443     Document Type: Article

References (28)

1. Abdelghany S, Hughes J, Lammers J, Wellbrock B, Buffington PJ, Shank RA III: Biofeedback and electrical stimulation therapy for treating urinary incontinence and voiding dysfunction: One center's experience. Urol Nurs 21 (6):401-405, 410, 2001.
2. American Psychiatric Association (APA): Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
3. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit hyperactivity disorder. Neuropsychopharmacology 27(5):699-711, 2002.
4. Cigna RM, Chiaramonte C, Piscopo A, Cataliotti F: Urodynamic evaluation in children with enuresis. Pediatr Med Chir 24(5):363-367, 2002.
5. Cosso SE: Enuresis. South Med J 95(2):183-187, 2002.
6. Dahl RE: Sleep disorders. In: Textbook of pediatric neuropsychiatry. Coffey CE, Brumback RA, (eds.). Washington, DC: American Psychiatric Press, Inc., 1998, pp. 821-838.
7. De Grazia E, Cimador M: Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders. Minerva Pediatr 51(5):149-152, 1999.
8. Djurhuus JC, Rittig S: Nocturnal enuresis. Curr Opin Urol 12(4):317-320, 2002.
9. El Hemaly AK: Nocturnal enuresis: Pathogenesis and treatment. Int Urogynecol J Pelvic Floor Dysfunct 9(3):129-131, 1998.
10. Glazener CM, Evans JH: Simple behavioural and physical interventions for nocturnal enuresis in children. Cochrane Database Syst Rev (2):CD003637, 2002.
11. Glazener CM, Evans JH: Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev (2):CD002117, 2000.
12. Hvistendahl GM, Rawashdeh YF, Kamperis K, Hansen MN, Rittig S, Djurhuus JC: The relationship between desmopressin treatment and voiding pattern in children. BJU Int 89(9):917-922, 2002.
13. Jalkut MW, Lerman SE, Churchill BM: Enuresis. Pediatr Clin North Am 48(6):1461-1488, 2001.
14. Kaneko K, Fujinaga S, Ohtomo Y, Shimizu T, Yamashiro Y: Combined pharmacotherapy for nocturnal enuresis. Pediatr Nephrol 16(8):662-664, 2001.
15. Klein J: Management of primary nocturnal enuresis. Urol Nurs 21(2):71-76, 2001.
16. Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D: Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biol Psychiatry 53:112-120, 2003.
17. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D: Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized placebo-controlled study. Am J Psychiatry 159(11):1896-1901, 2002.
18. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T: Atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 118(5):E83, 2001.
19. National Institute of Neurological Disorders and Stroke: Sleep hygiene. (www.neurologychannel.com/sleepdisorders/treatment.shtml), 2004.
20. Pennesi M, Pitter M, Bordugo A, Minisini S, Peratoner L: Behavioral therapy for primary nocturnal enuresis. J Urol 171(1):408-410, 2004.
21. Rapoport JL, Mikkelsen EJ, Zavadil A, Nee L, Gruenau C, Mendelson W, Gillin JC: Childhood enuresis. II. Psychopathology, tricyclic concentration in plasma, and antienuretic effect. Arch Gen Psychiatry 37(10):1146-1152, 1980.
22. Robson LM, Leung AK: Urotherapy recommendations for bedwetting. J Natol Med Assoc 94(7):577-580, 2002.
23. Tappin DM, Clarke L, Ross LM, Bell M: A nocturnal enuresis service for a deprived inner city. Acta Paediatr 92(1):97-102, 2003.
24. Thiedke CC: Nocturnal enuresis. Am Fam Physician 67(7):1499-1506, 2003.
25. Tomasi PA, Siracusano S, Monni AM, Mela G, Delitala G: Decreased nocturnal urinary antidiuretic hormone excretion in enuresis is increased by imipramine. BJU 88(9):932-937, 2001.
26. Van Kampen M, Bogaert G, Feys H, Baert L, De Raeymaeker I, De Weerdt W: High initial efficacy of full-spectrum therapy for nocturnal enuresis in children and adolescents. BJU 90(1):84-87, 2002.
27. Yang SS, Chiou YH, Lin CY, Cher TW, Yu TJ, Lin AT, Chen SC, Lai MK: Treatment guideline of enuresis in Taiwan. Acta Paediatr Taiwan 42(5):271-272, 2001.
28. Yeung CK: Nocturnal enuresis (bedwetting). Curr Opin Urol 13(4):337-343, 2003.